SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010390
Filing Date
2021-08-05
Accepted
2021-08-05 07:31:56
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20210630x10q.htm   iXBRL 10-Q 1605736
2 EX-10.2 edit-20210630xex10d2.htm EX-10.2 30455
3 EX-10.3 edit-20210630xex10d3.htm EX-10.3 16734
4 EX-31.1 edit-20210630xex31d1.htm EX-31.1 15624
5 EX-31.2 edit-20210630xex31d2.htm EX-31.2 15142
6 EX-32.1 edit-20210630xex32d1.htm EX-32.1 10137
7 GRAPHIC edit-20210630xex10d2001.jpg GRAPHIC 2217
  Complete submission text file 0001558370-21-010390.txt   5722950

Data Files

Seq Description Document Type Size
8 EX-101.SCH edit-20210630.xsd EX-101.SCH 24978
9 EX-101.CAL edit-20210630_cal.xml EX-101.CAL 42237
10 EX-101.DEF edit-20210630_def.xml EX-101.DEF 94948
11 EX-101.LAB edit-20210630_lab.xml EX-101.LAB 322648
12 EX-101.PRE edit-20210630_pre.xml EX-101.PRE 220923
13 EXTRACTED XBRL INSTANCE DOCUMENT edit-20210630x10q_htm.xml XML 1076659
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 211146342
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences